養殖海鮮生產系統市場機會、成長促進因素、產業趨勢分析及預測（2025-2034年）

2024 年全球養殖海鮮生產系統市場價值為 13 億美元，預計到 2034 年將以 7.6% 的複合年成長率成長至 28 億美元。

對細胞農業的投資不斷成長以及循環水產養殖系統（RAS）的快速發展是推動這一成長的主要因素。該產業正經歷著商業化規模生產的明顯轉型，對先進生物反應器系統和智慧監控技術的需求正在加速成長。美國食品藥物管理局（FDA）和美國農業部（USDA）的支持性監管框架，以及生物技術和永續蛋白質生產品質標準的建立，為市場擴張奠定了堅實的基礎。養殖海鮮系統透過整合自動化、智慧感測器和精準控制技術，最佳化生產效率，正在革新現代水產養殖。隨著永續蛋白質替代品在全球範圍內獲得認可，這些系統正被視為滿足未來食品需求並維持環境平衡的可行解決方案。細胞水產養殖的可擴展性和製程最佳化是這些技術快速商業化的關鍵。大量的研究經費以及使大規模海鮮養殖成為現實且永續前景的創新，進一步推動了市場的蓬勃發展。

至2034年，3D生物列印系統市場將以12.9%的複合年成長率成長。這項技術正在革新具有複雜組織結構的海鮮生產方式，有助於開發高價值的高階產品。 3D生物列印技術的日益普及歸功於其能夠提供獨特的產品質地和先進的差異化優勢，而這些優勢是傳統生產流程無法比擬的。

2024年，中試規模系統市場規模達4.375億美元，佔總市佔率的35%。這些系統在製程驗證、規模化測試和監管準備方面發揮著至關重要的作用。模組化循環水產養殖系統（RAS）和中試生物反應器因其靈活性和成本效益，在全面部署前測試生產效率方面越來越受歡迎。中試規模技術的應用支持細胞農業和現代水產養殖的逐步擴張策略，確保在商業化過程中實現最佳製程性能並降低風險。

2024年北美養殖海鮮生產系統市場規模為4.375億美元，預計2025年至2034年將以8.7%的複合年成長率成長。北美憑藉其先進的生物技術基礎設施和健全的監管環境，在該行業保持主導地位。該地區在養殖海鮮生產中對自動化系統和生物技術創新展現出極高的應用率。美國持續的技術發展和加拿大水產養殖業的進步不斷鞏固該地區的市場地位。

全球養殖海鮮生產系統市場的主要參與者包括 Solaris Biotech（唐納森）、Hamilton Company、賽默飛世爾科技、賽多利斯、Eppendorf、Steakholder Foods、CytoNest、Culture Biosciences、Prolific Machines、Molecular Devices、Ark Biotech、E-TechTechs、Civa（丹納赫特Meats、EdiMembre 和 Hitachi Zosen。領先企業正致力於透過開發可擴展的自動化生物加工系統來擴大產能。他們正積極尋求與研究機構和新創公司進行策略合作，以加速細胞培養和組織工程領域的創新。各公司正大力投資智慧監控技術和數位化自動化，以提高系統效率並降低營運成本。透過先進的設計、精準的控制和整合的物聯網功能來實現產品差異化是他們關注的重點領域。

目錄

第1章：方法論與範圍

第2章：執行概要

第3章：行業洞察

• 產業生態系分析
  • 供應商格局
  • 利潤率
  • 每個階段的價值增加
  • 影響價值鏈的因素
  • 中斷
• 產業影響因素
  • 促進要素
  • 陷阱與挑戰
  • 機會
• 成長潛力分析
• 監管環境
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東和非洲
• 波特的分析
• PESTEL 分析
• 價格趨勢
  • 按地區
  • 按產品規格
• 未來市場趨勢
• 技術與創新格局
  • 當前技術趨勢
  • 新興技術
• 專利格局
• 貿易統計（HS編碼）（註：僅提供重點國家的貿易統計資料）
  • 主要進口國
  • 主要出口國
• 永續性和環境方面
  • 永續實踐
  • 減少廢棄物策略
  • 生產中的能源效率
  • 環保舉措
• 碳足跡考量

第4章：競爭格局

• 介紹
• 公司市佔率分析
  • 按地區
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • MEA
• 公司矩陣分析
• 主要市場參與者的競爭分析
• 競爭定位矩陣
• 關鍵進展
  • 併購
  • 合作夥伴關係與合作
  • 新產品發布
  • 擴張計劃

第5章：市場估算與預測：依生產技術分類，2021-2034年

• 主要趨勢
• 監控系統
• 生物反應器系統
• 細胞培養系統
• 鷹架系統
• 3D生物列印系統

第6章：市場估算與預測：依營運規模分類，2021-2034年

• 主要趨勢
• 實驗室規模系統
• 中試規模系統
• 商業規模系統

第7章：市場估算與預測：依自動化程度分類，2021-2034年

• 主要趨勢
• 手動作業系統
• 半自動化系統
• 全自動系統
• 整合式交鑰匙解決方案

第8章：市場估算與預測：依產品應用分類，2021-2034年

• 主要趨勢
• 魚類生產系統
• 貝類生產系統
• 結構化產品製造
• 非結構化產品加工
• 混合產品製造
• 特色及高階產品

第9章：市場估計與預測：依地區分類，2021-2034年

• 主要趨勢
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 歐洲其他地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 拉丁美洲其他地區
• 中東和非洲
  • 沙烏地阿拉伯
  • 南非
  • 阿拉伯聯合大公國
  • 中東和非洲其他地區

第10章：公司簡介

• Solaris Biotech (Donaldson)
• Hamilton Company
• Thermo Fisher Scientific
• Sartorius
• Eppendorf
• Steakholder Foods
• CytoNest
• Culture Biosciences
• Prolific Machines
• Molecular Devices
• Ark Biotech
• E-Tech Group
• Cytiva (Danaher)
• Merck KGaA/EMD
• Applikon Biotechnology

The Global Cultivated Seafood Production Systems Market was valued at USD 1.3 Billion in 2024 and is estimated to grow at a CAGR of 7.6% to reach USD 2.8 Billion by 2034.

Growing investment in cellular agriculture and rapid advancements in recirculating aquaculture systems (RAS) are major factors driving this growth. The industry is witnessing a clear transition toward commercial-scale production, with demand for advanced bioreactor systems and smart monitoring technologies accelerating. Supportive regulatory frameworks from the FDA and USDA, along with the establishment of quality standards for biotechnology and sustainable protein manufacturing, are providing a strong foundation for market expansion. Cultivated seafood systems are revolutionizing modern aquaculture by integrating automation, smart sensors, and precision control technologies that optimize production efficiency. As sustainable protein alternatives gain global traction, these systems are being positioned as a viable solution for meeting future food demands while maintaining environmental balance. Enhanced scalability and process optimization in cellular aquaculture are key to the rapid commercialization of these technologies. The market's momentum is further fueled by significant funding for research, coupled with innovations that make large-scale seafood cultivation a realistic and sustainable prospect.

The 3D bioprinting systems segment will grow at a CAGR of 12.9% through 2034. This technology is transforming the production of structured seafood with complex tissue composition, enabling the development of high-value, premium products. The growing adoption of 3D bioprinting is attributed to its ability to deliver unique product textures and advanced differentiation compared to conventional production processes.

The pilot-scale systems segment accounted for USD 437.5 million in 2024, representing a 35% share. These systems play an essential role in process validation, scalability testing, and regulatory readiness. Modular RAS and pilot bioreactors are gaining popularity for their flexibility and cost-effectiveness in testing production efficiency before full-scale deployment. The adoption of pilot-scale technologies supports gradual expansion strategies in both cellular agriculture and modern aquaculture, ensuring optimal process performance and risk reduction during commercialization.

North America Cultivated Seafood Production Systems Market was valued at USD 437.5 million in 2024 and is anticipated to grow at a CAGR of 8.7% from 2025 to 2034. North America maintains its dominance in this industry due to its advanced biotechnology infrastructure and strong regulatory environment. The region demonstrates a high rate of adoption for automated systems and biotechnological innovations in cultivated seafood production. Ongoing technological developments in the United States and progressive aquaculture advancements in Canada continue to strengthen the region's market position.

Major players in the Global Cultivated Seafood Production Systems Market include Solaris Biotech (Donaldson), Hamilton Company, Thermo Fisher Scientific, Sartorius, Eppendorf, Steakholder Foods, CytoNest, Culture Biosciences, Prolific Machines, Molecular Devices, Ark Biotech, E-Tech Group, Cytiva (Danaher), Merck KGaA/EMD, Applikon Biotechnology, Matrix Meats, EdiMembre, and Hitachi Zosen. Leading companies are focusing on expanding their production capacities through the development of scalable and automated bioprocessing systems. Strategic collaborations with research institutions and startups are being pursued to accelerate innovation in cell culture and tissue engineering. Firms are heavily investing in smart monitoring technologies and digital automation to enhance system efficiency and reduce operational costs. Product differentiation through advanced design, precision control, and integrated IoT capabilities is a major area of focus.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope and definition
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Data mining sources
  • 1.3.1 Global
  • 1.3.2 Regional/Country
• 1.4 Base estimates and calculations
  • 1.4.1 Base year calculation
  • 1.4.2 Key trends for market estimation
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
• 1.6 Forecast model
• 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis
• 2.2 Key market trends
  • 2.2.1 Production technology trends
  • 2.2.2 Scale of operation trends
  • 2.2.3 Automation level trends
  • 2.2.4 Product application trends
  • 2.2.5 Regional trends
• 2.3 TAM Analysis, 2025-2034
• 2.4 CXO perspectives: Strategic imperatives
  • 2.4.1 Executive decision points
  • 2.4.2 Critical success factors
• 2.5 Future Outlook and Strategic Recommendations

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
  • 3.1.1 Supplier landscape
  • 3.1.2 Profit margin
  • 3.1.3 Value addition at each stage
  • 3.1.4 Factor affecting the value chain
  • 3.1.5 Disruptions
• 3.2 Industry impact forces
  • 3.2.1 Drivers
  • 3.2.2 Pitfalls & Challenges
  • 3.2.3 Opportunities
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 Asia Pacific
  • 3.4.4 Latin America
  • 3.4.5 Middle East & Africa
• 3.5 Porter's analysis
• 3.6 PESTEL analysis
• 3.7 Price trends
  • 3.7.1 By region
  • 3.7.2 By product format
• 3.8 Future market trends
• 3.9 Technology and Innovation landscape
  • 3.9.1 Current technological trends
  • 3.9.2 Emerging technologies
• 3.10 Patent Landscape
• 3.11 Trade statistics (HS code) ( Note: the trade statistics will be provided for key countries only)
  • 3.11.1 Major importing countries
  • 3.11.2 Major exporting countries
• 3.12 Sustainability and environmental aspects
  • 3.12.1 Sustainable practices
  • 3.12.2 Waste reduction strategies
  • 3.12.3 Energy efficiency in production
  • 3.12.4 Eco-friendly initiatives
• 3.13 Carbon footprint consideration

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
  • 4.2.1 By region
    • 4.2.1.1 North America
    • 4.2.1.2 Europe
    • 4.2.1.3 Asia Pacific
    • 4.2.1.4 LATAM
    • 4.2.1.5 MEA
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Mergers & acquisitions
  • 4.6.2 Partnerships & collaborations
  • 4.6.3 New Product Launches
  • 4.6.4 Expansion Plans

Chapter 5 Market Estimates and Forecast, By Production Technology, 2021-2034 (USD Million & Units)

• 5.1 Key trends
• 5.2 Monitoring & control systems
• 5.3 Bioreactor systems
• 5.4 Cell culture systems
• 5.5 Scaffolding systems
• 5.6 3d bioprinting systems

Chapter 6 Market Estimates and Forecast, By Scale of Operation, 2021-2034 (USD Million & Units)

• 6.1 Key trends
• 6.2 Laboratory scale systems
• 6.3 Pilot scale systems
• 6.4 Commercial scale systems

Chapter 7 Market Estimates and Forecast, By Automation Level, 2021-2034 (USD Million & Units)

• 7.1 Key trends
• 7.2 Manual operation systems
• 7.3 Semi-automated systems
• 7.4 Fully automated systems
• 7.5 Integrated turnkey solutions

Chapter 8 Market Estimates and Forecast, By Product Application, 2021-2034 (USD Million & Units)

• 8.1 Key trends
• 8.2 Finfish production systems
• 8.3 Shellfish production systems
• 8.4 Structured product manufacturing
• 8.5 Unstructured product processing
• 8.6 Hybrid product manufacturing
• 8.7 Specialty & premium products

Chapter 9 Market Estimates and Forecast, By Region, 2021-2034 (USD Million & Units)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 India
  • 9.4.3 Japan
  • 9.4.4 Australia
  • 9.4.5 South Korea
  • 9.4.6 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
  • 9.5.4 Rest of Latin America
• 9.6 Middle East and Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 South Africa
  • 9.6.3 UAE
  • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

• 10.1 Solaris Biotech (Donaldson)
• 10.2 Hamilton Company
• 10.3 Thermo Fisher Scientific
• 10.4 Sartorius
• 10.5 Eppendorf
• 10.6 Steakholder Foods
• 10.7 CytoNest
• 10.8 Culture Biosciences
• 10.9 Prolific Machines
• 10.10 Molecular Devices
• 10.11 Ark Biotech
• 10.12 E-Tech Group
• 10.13 Cytiva (Danaher)
• 10.14 Merck KGaA/EMD
• 10.15 Applikon Biotechnology